Filing Details

Accession Number:
0001209191-19-039192
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-26 20:40:24
Reporting Period:
2019-06-26
Accepted Time:
2019-06-26 20:40:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1027035 W John Childs C/O Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven CT 06510
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2019-06-26 10,000 $40.37 10,000 No 4 P Indirect By John W Childs 2013 Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By John W Childs 2013 Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,826,938 Direct
Footnotes
  1. Includes 2,719,438 shares that were previously held in the John W. Childs 2013 Revocable Trust, which are now held directly by the Reporting Person.